Use D10 for Persistent Hypoglycemia
For persistent hypoglycemia requiring continuous IV dextrose infusion, use D10W (10% dextrose) at a constant infusion rate of 100 mL/kg per 24 hours (7 mg/kg per minute), titrated to achieve normoglycemia. 1
Rationale for D10 Over D5
The key distinction is between acute bolus treatment versus persistent/maintenance therapy:
For Acute Hypoglycemia Treatment
- Initial bolus: Either D10 or D50 can be used, but D10 is preferred 2
- D10 advantages: Titrated 5-g aliquots (50 mL of D10) restore mental status in ~8 minutes with lower median total dose (10g vs 25g), achieving better post-treatment glucose (112 mg/dL vs 169 mg/dL, p=0.03) and avoiding overcorrection 2
- D50 risks: Higher doses required, excessive post-treatment hyperglycemia, and reports of cardiac arrest/hyperkalemia with rapid repeated administration 2
For Persistent Hypoglycemia (Your Question)
D10W is specifically indicated for continuous infusion when hypoglycemia persists or recurs 1:
- Dose: 200 mg/kg as D10W only, given as constant infusion at 100 mL/kg per 24 hours 1
- Titration: Rate should be adjusted to achieve normoglycemia, as hyperglycemia has its own adverse CNS effects 1
- Monitoring: Glucose, sodium, and potassium levels require careful monitoring 1
D5W is insufficient for persistent hypoglycemia—it provides only 5g dextrose per 100mL, which is inadequate to maintain normoglycemia in patients with ongoing hypoglycemic tendency.
Clinical Algorithm for Persistent Hypoglycemia
Initial bolus: Give 0.5-1.0 g/kg dextrose (5-10 mL/kg of D10W) 1
Start continuous infusion:
Monitor and titrate:
Prevent rebound hypoglycemia:
Important Caveats
Avoid D5W for persistent hypoglycemia because:
- Provides only 50g dextrose per liter (insufficient glucose delivery)
- Used primarily for maintenance fluids, not hypoglycemia treatment
- The evidence and guidelines specifically recommend D10W for continuous infusion 1
D50W considerations:
- Irritating to peripheral veins; dilution to 25% dextrose is desirable 1
- Reserved for central venous administration or emergency bolus treatment 3
- Maximum rate: 0.5 g/kg/hour to avoid glycosuria 3
Monitor for complications:
- Hyperglycemia from overcorrection (has its own CNS toxicity) 1
- Electrolyte deficits (particularly potassium and phosphate) 3
- Extravasation injury with concentrated solutions 4
- Rebound hypoglycemia when stopping infusion 3
The evidence consistently supports D10W as the appropriate concentration for persistent hypoglycemia requiring continuous infusion, with D5W being inadequate and D50W being too concentrated for safe peripheral administration.